OSCR

Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial.

A correction to this paper has been published: the notice, 42509314, from Europe PMC.

Overview

Authors: Mohammad Ali Salehinejad1,2, Marzieh Abdi3, Mohsen Dadashi3, Maryam Habibi3, Amir-Homayun Hallajian4, Kiomars Sharifi5, Ali Khadem6, Ricardo Salvador7, Giulio Ruffini7, Michael A. Nitsche2,8,9
  1. Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Medical Faculty, RWTH Aachen University,Aachen, Germany
  2. Department of Psychology and Neurosciences, Leibniz Research Centre for Working Environment and Human Factors,Dortmund, Germany
  3. Department of Clinical Psychology, Faculty of Medicine, Zanjan University of Medical Sciences,Zanjan, Iran
  4. Donders Institute for Brain, Cognition, and Behaviour, Radboud University,Nijmegen, The Netherlands
  5. Department of Information Technology and Electrical Engineering, ETH Zurich,Zurich, Switzerland
  6. Department of Biomedical Engineering, Faculty of Electrical Engineering, K. N. Toosi University of Technology,Tehran, Iran
  7. Neuroelectrics Barcelona,Barcelona, Spain
  8. Bielefeld University, University Hospital OWL, Protestant Hospital of Bethel Foundation, University Clinic of Psychiatry and Psychotherapy,Bielefeld, Germany
  9. German Center for Mental Health,Bochum, Germany
Journal: Molecular psychiatry, volume 31, issue 8, pages 4632-4644
Dates: received 24 May 2025; accepted 16 March 2026; published online 2 April 2026; in print 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1038/s41380-026-03560-0 · PMID 41927768 · PMCID PMC13364697 · OpenAlex W7148427029
Open access: hybrid, a free copy (OpenAlex)
Categories: other (modality), human (organism), depression (population), clinical / translational (subfield)
Methods: Connectivity, Statistics, Smoothing, state filtering, decompositions, Preprocessing, Spectral & time-frequency
Keywords: Depression, Neuroscience
MeSH: Major Depressive Disorder*, Transcranial Direct Current Stimulation*, Adult, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Treatment Outcome (* major topic)
Topic: Transcranial Magnetic Stimulation Studies (Neurology, Neuroscience), according to OpenAlex
Funding: SFB 1280, project A6, and by the German Centre of Mental Health (Project Num-ber 01EE2302D)
Citations: cited by 1 paper (Europe PMC); 74 references in the paper
Notices: A correction to this paper has been published (42509314, from Europe PMC)

Abstract

Major depressive disorder is a prevalent mental condition and the second most disabling disease. Transcranial direct current stimulation (tDCS), with advantages such as affordability, home-use application, and mild side effects, has been proposed for treating depression. Yet, its clinical efficacy is not established. Optimizing tDCS interventions for more effective and feasible clinical application is a need and topic of ongoing research. This randomized, sham‑controlled trial compares the efficacy of computationally optimized multichannel tDCS (4 mA), a less source-demanding alternative for personalized tDCS, vs conventional tDCS (2 mA) for treating unipolar depression. Seventy-one patients were randomly assigned to the optimized multichannel tDCS, conventional tDCS, and sham tDCS arms, of whom 60 provided endpoint data. In the optimized multichannel tDCS, electrical current was delivered via 7 small electrodes (max 1.65 mA per electrode; total injected current per polarity ≈ 4 mA [precisely 3.99 mA]) while in the conventional (2 mA per electrode) and sham tDCS, two 35 cm² sponge electrodes were used. Intervention efficacy and treatment response were evaluated before the intervention, at weeks 2, 4, 6, and 1- and 3-month post-intervention, and cognitive functions and brain connectivity changes were assessed before and after the intervention. Both active tDCS interventions significantly reduced depressive symptoms compared to the sham group after the intervention. The optimized multichannel tDCS demonstrated earlier and stronger symptom alleviation than conventional tDCS. It additionally improved cognitive control and modulated functional connectivity markers associated with depression pathophysiology. The mean change in the primary clinical outcome from baseline to the study endpoint was 6.30 in the sham group and 13.50 and 21.50 in the conventional and multichannel tDCS groups, with corresponding response rate (≥50% symptom reduction) of 20% (4/20), 45% (9/20), and 75% (15/20), respectively. Blinding was unsuccessful only in the optimized multichannel arm, likely due to more intense stimulation-related sensations, however, this did not impact clinical outcomes. The optimized multichannel 4 mA tDCS shows clinical efficacy for treating depression, warranting further investigations in the future. Trial Registration Identifier: NCT06165445 / IRCT20210517051330N1.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

The data used in this trial will be publicly available at OSF upon manuscript publication via: https://osf.io/xm4vq/overview?view_only=8d2e65ed25ec437c911eaecb8c34ae5d

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: n/a → Springer Nature

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 2 keywords, 9 MeSH terms, 1 funder, 73 references, 1 integrity notice.

Cite

This paper

Salehinejad, M. A., Abdi, M., Dadashi, M., Habibi, M., Hallajian, A.-H., Sharifi, K., Khadem, A., Salvador, R., Ruffini, G., & Nitsche, M. A. (2026). Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial. Molecular psychiatry, 31(8), 4632-4644. https://doi.org/10.1038/s41380-026-03560-0

BibTeX

@article{salehinejad2026optimized,
author = {Salehinejad, Mohammad Ali and Abdi, Marzieh and Dadashi, Mohsen and Habibi, Maryam and Hallajian, Amir-Homayun and Sharifi, Kiomars and Khadem, Ali and Salvador, Ricardo and Ruffini, Giulio and Nitsche, Michael A.},
title = {{Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial}},
journal = {Molecular psychiatry},
year = {2026},
month = apr,
volume = {31},
number = {8},
pages = {4632--4644},
publisher = {Springer Nature},
issn = {1359-4184},
doi = {10.1038/s41380-026-03560-0},
url = {https://doi.org/10.1038/s41380-026-03560-0},
pmid = {41927768},
pmcid = {PMC13364697}
}

RIS

TY - JOUR
AU - Salehinejad, Mohammad Ali
AU - Abdi, Marzieh
AU - Dadashi, Mohsen
AU - Habibi, Maryam
AU - Hallajian, Amir-Homayun
AU - Sharifi, Kiomars
AU - Khadem, Ali
AU - Salvador, Ricardo
AU - Ruffini, Giulio
AU - Nitsche, Michael A.
TI - Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial
T2 - Molecular psychiatry
J2 - Mol Psychiatry
PY - 2026
DA - 2026/04/02
VL - 31
IS - 8
SP - 4632
EP - 4644
SN - 1359-4184
PB - Springer Nature
DO - 10.1038/s41380-026-03560-0
UR - https://doi.org/10.1038/s41380-026-03560-0
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s41380-026-03560-0",
"type": "article-journal",
"title": "Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial",
"container-title": "Molecular psychiatry",
"author": [
{
"family": "Salehinejad",
"given": "Mohammad Ali"
},
{
"family": "Abdi",
"given": "Marzieh"
},
{
"family": "Dadashi",
"given": "Mohsen"
},
{
"family": "Habibi",
"given": "Maryam"
},
{
"family": "Hallajian",
"given": "Amir-Homayun"
},
{
"family": "Sharifi",
"given": "Kiomars"
},
{
"family": "Khadem",
"given": "Ali"
},
{
"family": "Salvador",
"given": "Ricardo"
},
{
"family": "Ruffini",
"given": "Giulio"
},
{
"family": "Nitsche",
"given": "Michael A."
}
],
"container-title-short": "Mol Psychiatry",
"volume": "31",
"issue": "8",
"page": "4632-4644",
"DOI": "10.1038/s41380-026-03560-0",
"PMID": "41927768",
"PMCID": "PMC13364697",
"ISSN": "1359-4184",
"publisher": "Springer Nature",
"URL": "https://doi.org/10.1038/s41380-026-03560-0",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
2
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12967-024-05638-1
Repeated prefrontal tDCS for improving mental health and cognitive deficits in multiple sclerosis: a randomized, double-blind, parallel-group study.
Journal: Journal of translational medicine
In common: other, clinical / translational, 10 references, 2 authors
[2] doi:10.1038/s41398-024-02736-y
Targeting the prefrontal-supplementary motor network in obsessive-compulsive disorder with intensified electrical stimulation in two dosages: a randomized, controlled trial.
Journal: Translational psychiatry
In common: depression, other, clinical / translational, 9 references, 2 authors
[3] doi:10.1038/s41537-025-00720-z
Cognitive and emotional effects of bilateral prefrontal anodal tDCS and high-frequency tRNS in schizophrenia: a randomized sham-controlled study.
Journal: Schizophrenia (Heidelberg, Germany)
In common: other, 8 references, author Mohammad Ali Salehinejad
[4] doi:10.7554/elife.69308 [code]
Sleep-dependent upscaled excitability, saturated neuroplasticity, and modulated cognition in the human brain.
Journal: eLife
In common: other, 3 references, 2 authors
[5] doi:10.3390/jcm13185358 [code]
Metaanalysis of Repetitive Transcranial Magnetic Stimulation (rTMS) Efficacy for OCD Treatment: The Impact of Stimulation Parameters, Symptom Subtype and rTMS-Induced Electrical Field.
Journal: Journal of clinical medicine
In common: other, clinical / translational, 4 references, author Mohammad Ali Salehinejad
[6] doi:10.1038/s41746-026-02575-9
A multicenter randomized clinical trial of portable transcranial alternating current stimulation for major depressive disorder.
Journal: NPJ digital medicine
In common: depression, other, clinical / translational, 6 references
[7] doi:10.3390/e26110953 [code]
The Algorithmic Agent Perspective and Computational Neuropsychiatry: From Etiology to Advanced Therapy in Major Depressive Disorder.
Journal: Entropy (Basel, Switzerland)
In common: depression, 7 references
[8] doi:10.1016/j.cnp.2022.05.002
Non-invasive brain stimulation and neuroenhancement.
Journal: Clinical neurophysiology practice
In common: other, clinical / translational, 3 references, author Michael A. Nitsche
[9] doi:10.1007/s00221-022-06358-y [code]
Consolidation of motor sequence learning eliminates susceptibility of SMAproper to TMS: a combined rTMS and cTBS study.
Journal: Experimental brain research
In common: other, 2 authors
[10] doi:10.1162/imag.a.140
Phase-synchronized 40 Hz tACS and iTBS effects on gamma oscillations.
Journal: Imaging neuroscience (Cambridge, Mass.)
In common: other, 3 references, author Mohammad Ali Salehinejad

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.